Search Results - Dona Fleishaker

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial by Mikkel Østergaard, Joseph Wu, Lara Fallon, Sarah P. Sherlock, Cunshan Wang, Dona Fleishaker, Keith S. Kanik, Walter P. Maksymowych

    Published in Rheumatology and Therapy (2023-06-01)
    Get full text
    Article


  2. 2

    Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, d... by Filip van den Bosch, Vibeke Strand, Cunshan Wang, Joseph C Cappelleri, Joseph Wu, Marina Magrey, James Cheng-Chung Wei, Victoria Navarro-Compán, Lisy Wang, Lara Fallon, Dona Fleishaker, Oluwaseyi Dina

    Published in RMD Open (2022-06-01)
    Get full text
    Article


  3. 3

    Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study by Peter Nash, Laura C. Coates, Alan J. Kivitz, Philip J. Mease, Dafna D. Gladman, José A. Covarrubias-Cobos, Oliver FitzGerald, Dona Fleishaker, Cunshan Wang, Joseph Wu, Ming-Ann Hsu, Sujatha Menon, Lara Fallon, Ana Belén Romero, Keith S. Kanik

    Published in Rheumatology and Therapy (2020-06-01)
    Get full text
    Article


Search Tools: